Name Development Level Target Family
Name Description
rituximab A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.
TCRDv4.6.9
DrugCentral Indication
DrugCentral
rituximab